37. 膿疱性乾癬(汎発型)
[臨床試験数:58,薬物数:50(DrugBank:18),標的遺伝子数:17,標的パスウェイ数:96

Searched query = "Generalised pustular psoriasis", "Pustular psoriasis", "Herpetic impetigo", "Generalization of acrodermatitis continua", "Generalization of dermatitis continua of the extremities"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03619902
(ClinicalTrials.gov)
March 4, 201919/7/2018A Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Generalized Pustular PsoriasisA Single Arm Multiple Dose Study to Assess the Efficacy and Safety of ANB019 in Subjects With Generalized Pustular PsoriasisGeneralized Pustular PsoriasisDrug: ANB019AnaptysBio, Inc.NULLActive, not recruiting18 Years75 YearsAll10Phase 2United States;Korea, Republic of;Poland;United Kingdom
2EUCTR2017-004021-33-GB
(EUCTR)
04/05/201820/12/2017To Assess the Efficacy and Safety of ANB019 in Subjects with Generalized Pustular PsoriasisA Single Arm Multiple Dose Study to Assess the Efficacy and Safety of ANB019 in Subjects with Generalized Pustular Psoriasis - ANB019-002 - Generalized Pustular Psoriasis Generalized Pustular Psoriasis (GPP)
MedDRA version: 21.0;Level: LLT;Classification code 10037159;Term: Psoriasis pustular;System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
AnaptysBio Inc.NULLAuthorised-recruitment may be ongoing or finished Female: yes
Male: yes
10Phase 2United States;United Kingdom